3200 Rare Diseases: Now Who Is Going to Cure Them?

To the patients who benefit from treatments that may have otherwise never been developed, your contribution would mean everything.

At-Cost AAV: From Production Cost to Patient Dose

Estimating the cost of manufacturing an AAV Gene Therapy by comparing industry benchmarks and published doses used in clinical trials.